共 50 条
- [45] LINEAR GROWTH IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) FOLLOWING 1ST MARROW RELAPSE TREATED WITH CHEMOTHERAPY OR BONE-MARROW TRANSPLANTATION (BMT) - A PEDIATRIC ONCOLOGY GROUP-STUDY CLINICAL RESEARCH, 1990, 38 (04): : A947 - A947
- [47] DETERMINATION OF THE MAXIMUM TOLERATED DOSE OF IDARUBICIN WHEN USED IN A COMBINATION CHEMOTHERAPY PROGRAM OF REINDUCTION OF CHILDHOOD ALL AT 1ST MARROW RELAPSE AND A PRELIMINARY ASSESSMENT OF TOXICITY COMPARED TO THAT OF DAUNORUBICIN - A REPORT FROM THE CHILDRENS-CANCER-STUDY-GROUP MEDICAL AND PEDIATRIC ONCOLOGY, 1992, 20 (02): : 124 - 129